Senseera

Senseera is a liquid biopsy company utilizing chromatin epigenomics to create the GEM BIOMARKERS™ platform. This platform offers non-invasive disease detection and monitoring through a simple blood test, providing detailed molecular insights for diagnosis and treatment. Its focus is on revolutionizing liver disease management and accelerating drug development in oncology and immunology.

Buy Funded Startups lists

Funding Round: Seed

Funding Amount: $7.1M

Date: 07-Jan-2025

Investors: Lightspeed Venture Partners, I-Next Capital, Lowy Medical Research Institute

Markets: Biotechnology, Diagnostics, Oncology, Immunology, Metabolic Diseases

HQ: Jerusalem, Israel

Founded: 2020

Website: https://www.senseerahealth.com/

LinkedIn: https://il.linkedin.com/company/senseerahealth

Twitter:

Instagram: